Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer.
Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, von Smolinski D, Kasper S, Sparwasser T, Gruber AD, Schuler M, Sakaguchi S, Roers A, Müller W, Hansen W, Buer J, Westendorf AM.
Pastille E, et al. Among authors: sakaguchi s.
Cancer Res. 2014 Aug 15;74(16):4258-69. doi: 10.1158/0008-5472.CAN-13-3065. Epub 2014 Jun 6.
Cancer Res. 2014.
PMID: 24906621